Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

249
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
249
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

508
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
508
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

62
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
62
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

401
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
401
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

136
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
136
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

115
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
115

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intensive Care Unit and Hospital Mortality for non-COVID Critically ill Patients Before, and During the COVID-19 Pandemic in Alberta Hospitals: Retrospective, Observational Cohort Study.

Journal of intensive care medicine·2026
Same author

Pre-liver transplant assessment of patients with acute-on-chronic liver failure: An international survey.

JHEP reports : innovation in hepatology·2026
Same author

Long Term Follow-Up After Transplantation in Propionic Acidemia: A Retrospective French Pediatric and Adult Cohort Study.

Journal of inherited metabolic disease·2026
Same author

Diagnosis and Management of Intracranial Hypertension in Acute Liver Failure.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same author

Liver Transplantation for HBV-Related Disease in France: NUC Type Before LT Is Associated With Patient Survival.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Belatacept in liver transplantation: Results of a national survey among French specialists.

Transplant immunology·2026

Related Experiment Video

Updated: Nov 11, 2025

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

24.0K

Hepatorenal Syndrome.

Saro Khemichian1, Claire Francoz2, Francois Durand3

  • 1Division of Gastroenterology/Liver, Keck School of Medicine, University of Southern California, 1510 San Pablo Street, Los Angeles, CA 90033, USA.

Critical Care Clinics
|March 23, 2021
PubMed
Summary
This summary is machine-generated.

Acute kidney injury is common in chronic liver disease patients, posing diagnostic challenges. Novel biomarkers and updated transplantation guidelines offer improved management strategies for this complex condition.

Keywords:
Acute kidney injuryAcute on chronic liver failureBiomarkersCirrhosisHepatorenal syndromeLiver transplantationModel end-stage liver diseaseSimultaneous liver kidney transplantation

More Related Videos

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
16:19

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

12.9K
Bilateral Renal Ischemia-Reperfusion Model for Acute Kidney Injury in Mice
02:45

Bilateral Renal Ischemia-Reperfusion Model for Acute Kidney Injury in Mice

Published on: February 2, 2024

2.1K

Related Experiment Videos

Last Updated: Nov 11, 2025

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

24.0K
Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
16:19

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

12.9K
Bilateral Renal Ischemia-Reperfusion Model for Acute Kidney Injury in Mice
02:45

Bilateral Renal Ischemia-Reperfusion Model for Acute Kidney Injury in Mice

Published on: February 2, 2024

2.1K

Area of Science:

  • Nephrology
  • Hepatology
  • Transplantation Medicine

Background:

  • Acute kidney injury (AKI) frequently complicates chronic liver disease (CLD), significantly worsening patient prognosis.
  • Traditional diagnostic markers like serum creatinine lack reliability in diagnosing AKI in CLD patients.
  • The pathophysiology of AKI in CLD is complex, involving portal hypertension, renal factors, and systemic inflammation.

Purpose of the Study:

  • To highlight the diagnostic challenges of AKI in CLD.
  • To discuss the multifactorial pathophysiology of AKI in CLD.
  • To review current and emerging management strategies, including novel biomarkers and transplantation criteria.

Main Methods:

  • Review of current literature on AKI in CLD.
  • Analysis of traditional and novel diagnostic markers.
  • Evaluation of established and evolving treatment modalities.
  • Examination of recent guidelines for liver and kidney transplantation.

Main Results:

  • Serum creatinine is an unreliable marker for AKI in CLD.
  • Novel biomarkers show promise for improved AKI diagnosis in this population.
  • Vasoconstrictors and albumin remain primary treatments.
  • New guidelines facilitate selection for simultaneous liver-kidney transplantation.

Conclusions:

  • Accurate diagnosis of AKI in CLD is critical due to poor prognosis.
  • Novel biomarkers and refined transplantation criteria are advancing patient care.
  • Post-transplant kidney injury remains a significant concern requiring further attention.